These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5496134)

  • 1. Lymphocytes and yellow fever. I. Transient virus refractory state following vaccination of man with the 17-D strain.
    Wheelock EF; Toy ST; Stjernholm RL
    J Immunol; 1970 Nov; 105(5):1304-6. PubMed ID: 5496134
    [No Abstract]   [Full Text] [Related]  

  • 2. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
    Adu FD; Adeniji JA; Tomori O; Adelasoye A
    Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yellow fever vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Jan; 32(52):679-82, 687-8. PubMed ID: 6419048
    [No Abstract]   [Full Text] [Related]  

  • 4. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
    Barrett AD; Teuwen DE
    Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The inhibiting effect of anticholera vaccination carried out simultaneously or at short intervals on yellow fever immunization. Is it real or assumed? Results of a retrospective study].
    Poveda JD; Raccurt CP; Le Fur R; M'Bailara L; Malvy JM; Le Bras M; Saliou P; Fleury HJ
    Bull Soc Pathol Exot; 1990; 83(4):529-35; discussion 535-6. PubMed ID: 2286006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous vaccination against cholera and yellow fever.
    Felsenfeld O; Wolf RH; Gyr K; Grant LS; Dutta NK
    Lancet; 1973 Mar; 1(7801):457-8. PubMed ID: 4120368
    [No Abstract]   [Full Text] [Related]  

  • 8. Benefit versus risk factors in immunization against yellow fever.
    Brès P
    Dev Biol Stand; 1979; 43():297-304. PubMed ID: 574841
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relation between viremia and sero-antibodies to the anti-yellow fever vaccination of persons vaccinated with strain 17D-EP].
    Santiago Actis A; Sa Fleitas MJ
    Rev Sanid Milit Argent; 1970; 69(1):51-63. PubMed ID: 5530987
    [No Abstract]   [Full Text] [Related]  

  • 10. Yellow fever vaccination.
    Middleton D
    Lancet; 1999 Jan; 353(9147):154. PubMed ID: 10023934
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of macrophages and antibody in resistance of mice against yellow fever virus.
    Zisman B; Wheelock EF; Allison AC
    J Immunol; 1971 Jul; 107(1):236-43. PubMed ID: 4326399
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relevant vaccination for travellers].
    Rieke B
    MMW Fortschr Med; 2003 Nov; 145(45):30-1. PubMed ID: 14699803
    [No Abstract]   [Full Text] [Related]  

  • 13. [Yellow fever (epidemiology and prevention)].
    Lienko BP
    Med Sestra; 1983 Feb; 42(2):35-8. PubMed ID: 6551634
    [No Abstract]   [Full Text] [Related]  

  • 14. Administration of time-expired yellow fever vaccine: public health response and results of a serological investigation.
    Allen KW; Nguyen-Van-Tam JS; Howells J
    Commun Dis Public Health; 1999 Jun; 2(2):141-2. PubMed ID: 10402751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yellow fever vaccine.
    Monath TP
    Expert Rev Vaccines; 2005 Aug; 4(4):553-74. PubMed ID: 16117712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of strains of yellow fever virus in gamma-irradiated mice.
    Fitzgeorge R; Bradish CJ
    J Gen Virol; 1980 Oct; 50(2):345-56. PubMed ID: 7463003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
    Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of encephalitis after anti-yellow fever vaccination with the 17 D strain].
    Louis JJ; Chopard P; Larbre F
    Pediatrie; 1981; 36(7):547-50. PubMed ID: 6119675
    [No Abstract]   [Full Text] [Related]  

  • 19. Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination.
    Martins MA; Silva ML; Elói-Santos SM; Ribeiro JG; Peruhype-Magalhães V; Marciano AP; Homma A; Kroon EG; Teixeira-Carvalho A; Martins-Filho OA
    Vaccine; 2008 Feb; 26(9):1173-84. PubMed ID: 18243433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yellow fever vaccines.
    Barrett AD
    Biologicals; 1997 Mar; 25(1):17-25. PubMed ID: 9167005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.